Brought to you by Nuclear Education Online (NEO)                    Volume 2, No. 11       January 2005

APhA Announces Awards

Four nuclear pharmacists will be recognized by APhA for their contributions to our professions at the annual meeting in April.  Congratulations to Clyde Cole for being selected to receive the William H. Briner Distinguished Achievement Award in Nuclear Pharmacy.  Bill Baker and Bob Beightol have been named APhA Fellows and Dick Hammes will receive the APhA Award of Merit.  Congratulations to all!
Former Nuclear Pharmacy Educator Dies
Norm Levit passed away in Albuquerque at the age of 83.    Much of his career was spent at the University of New Mexico where he served on the faculty of the College of Pharmacy and was the Associate Director of Radiopharmacy from 1976 to 1982. Norm taught many courses throughout his tenure at UNM, including Radiopharmacy Management through 2001.  He educated over 150 radiopharmacists in the best business practices for commercial nuclear pharmacy.  Norm is remembered as the person who brought community pharmacy management principles to the UNM Radiopharmacy and implemented the first formal customer service programs for commercial radiopharmacies.  


Proposed USP Chapter <797> Revisions
When <797> was introduced officially in the 27th Revision of the United States Pharmacopeia, USP 27, on January 1, 2004, it became enforceable by the U.S. Food and Drug Administration. It has since been adopted by some pharmacy regulatory and accrediting bodies, especially some U.S. state boards of pharmacy, and JCAHO. As of January 1, 2005, USP 28 is the official source of <797> See the USP website for a summary of revisions.
JNM Molecular Radiotherapy Supplement
The Journal of Nuclear Medicine has released a supplement issue dedicated to understanding radionuclide therapy, including 20 CE articles involving traditional therapies to new monoclonal antibodies and targeted gene therapy.  Articles also available online..

Feb.4 AMI Annual Meeting Early Registration Deadline
March 2 Deadline for APhA Meeting Early Registration Discount
Mar. 18-19 Clinical Pet/CT and Spect/CT Imaging of Cancer for Radiologists and Nuclear Physicians, Baltimore, MD
Mar. 18-23 Academy of Molecular Imaging Annual Meeting, Orlando, FL
April 1-5 APhA 2005 Annual Meeting, Orlando, FL
April 8-10 Pacific Northwest Chapter PET/CT Symposium
Coeur D'alene, Idaho
April 15-17 35th Annual Spring Meeting Mid-Eastern Chapter, SNM, Ocean City, MD
June 18-22 Society of Nuclear Medicine 52nd Annual Meeting
Toronto, Ontario, Canada
June 24-28 The 16th International Symposium on
Radiopharmaceutical Chemistry
, Iowa City
To subscribe to this mailing list click here.
To view previous issues

If this email does not view graphics properly go to

Patient motion is a considerable problem in diagnostic imaging. Factors which affect the final result of motion include: 
Amount of movement:  Less than 3 mm is not usually visually detectable.  Movement less than 6.5 mm is detectable, but is not usually significant. Movement of >13 mm frequently produces quantitative abnormalities. 
Type of movement: Axial movement (up & down) is usually more significant than lateral movement.
Time of movement:  Movement at the beginning or end of the study is less likely to result in image artifacts, whereas movement occurring at midaquisition has the worst effect.

A 73 year old white female with primary hyperparathyroidism presents at a follow-up visit and still complains of excessive fatigue, weakness and extremity pain. Continued....

2004 Nuclear Education Online
4301 W. Markham #522
Little Rock, AR  72205
For more information, contact Nicki Hilliard